Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talat Bessissow

Showing results (71-80 of 177) with videos related to

Pageof 18
Sort By:
Journal of Virus Eradication|March 5, 2021
Differences in HIV burden in the inflamed and non-inflamed colon from a person living with HIV and ulcerative colitisXiaorong Peng, Stéphane Isnard, John Lin, et al.
Inflammatory Bowel Diseases|May 31, 2018
Comparison of Endoscopic Dysplasia Detection Techniques in Patients With Ulcerative Colitis: A Systematic Review and Network Meta-analysisTalat Bessissow, Parambir S Dulai, Sophie Restellini, et al.
Biomedicines|April 23, 2022
Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?Gustavo Drügg Hahn, Petra Anna Golovics, Panu Wetwittayakhlang, et al.
Digestive Diseases and Sciences|May 22, 2021
Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic ReviewAlex Al Khoury, Bhairavi Balram, Talat Bessissow, et al.
Alimentary Pharmacology & Therapeutics|April 25, 2025
Letter: Re-Examining Seton Efficacy in Perianal Crohn's Disease-Critical Considerations for Outcome Measurement and Clinical Interpretation. Authors' ReplyJeffrey D McCurdy, Blair Macdonald, Greg Rosenfeld, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 13, 2019
Low endoscopy bleeding risk in patients with congenital bleeding disordersMarcel Tomaszewski, Marc Bienz, Omar Kherad, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2025
Editorial: Seton Use in Perianal Fistulising Crohn's Disease. Authors' ReplyJeffrey D McCurdy, Blair Macdonald, Greg Rosenfeld, et al.
World Journal of Gastroenterology|September 26, 2022
Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA studyTalat Bessissow, Geoffrey C Nguyen, Osman Tarabain, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 16, 2023
Real-world effectiveness and safety of ustekinumab in bio-naive patients with moderate-to-severe Crohn's disease: A Canadian multi-center studyTalat Bessissow, Neeraj Narula, Christopher Ma, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 31, 2024
Healthcare resource utilization following ustekinumab initiation among bio-naïve Canadian patients with moderately-to-severely active Crohn's diseaseTalat Bessissow, Neeraj Narula, Christopher Ma, et al.
Pageof 18

Showing results (71-80 of 177) with videos related to

Sort By:
Pageof 18
Journal of Virus Eradication|March 5, 2021
Differences in HIV burden in the inflamed and non-inflamed colon from a person living with HIV and ulcerative colitisXiaorong Peng, Stéphane Isnard, John Lin, et al.
Inflammatory Bowel Diseases|May 31, 2018
Comparison of Endoscopic Dysplasia Detection Techniques in Patients With Ulcerative Colitis: A Systematic Review and Network Meta-analysisTalat Bessissow, Parambir S Dulai, Sophie Restellini, et al.
Biomedicines|April 23, 2022
Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?Gustavo Drügg Hahn, Petra Anna Golovics, Panu Wetwittayakhlang, et al.
Digestive Diseases and Sciences|May 22, 2021
Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic ReviewAlex Al Khoury, Bhairavi Balram, Talat Bessissow, et al.
Alimentary Pharmacology & Therapeutics|April 25, 2025
Letter: Re-Examining Seton Efficacy in Perianal Crohn's Disease-Critical Considerations for Outcome Measurement and Clinical Interpretation. Authors' ReplyJeffrey D McCurdy, Blair Macdonald, Greg Rosenfeld, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 13, 2019
Low endoscopy bleeding risk in patients with congenital bleeding disordersMarcel Tomaszewski, Marc Bienz, Omar Kherad, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2025
Editorial: Seton Use in Perianal Fistulising Crohn's Disease. Authors' ReplyJeffrey D McCurdy, Blair Macdonald, Greg Rosenfeld, et al.
World Journal of Gastroenterology|September 26, 2022
Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA studyTalat Bessissow, Geoffrey C Nguyen, Osman Tarabain, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 16, 2023
Real-world effectiveness and safety of ustekinumab in bio-naive patients with moderate-to-severe Crohn's disease: A Canadian multi-center studyTalat Bessissow, Neeraj Narula, Christopher Ma, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 31, 2024
Healthcare resource utilization following ustekinumab initiation among bio-naïve Canadian patients with moderately-to-severely active Crohn's diseaseTalat Bessissow, Neeraj Narula, Christopher Ma, et al.
Pageof 18